EMA Authorised: Gardasil (human papillomavirus type 6 L1 protein;human papillomavirus type 11 L1 protein;human papillomavirus type 16 L1 protein;human papillomavirus type 18 L1 protein) — Merck Sharp & Dohme B.V.

View source ↗

Summary

The EMA authorised Gardasil, a quadrivalent human papillomavirus vaccine, for prevention of HPV infections and related diseases such as cervical dysplasia and g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dysplasia
• Genital Warts
• Human Papillomavirus Infection

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Status: Authorised. Therapeutic area: Papillomavirus Infections;Uterine Cervical Dysplasia;Condylomata Acuminata;Immunization. MAH: Merck Sharp & Dohme B.V.. Decision date: 20/10/2025